At the department of Hematology we are dedicated to improving the diagnosis and treatment of patients with hematological diseases. We perform basic and translational research to generate insight into the pathobiology of hematological diseases, and translate these findings into novel treatments for our patients.
In addition, we direct a wide variety of clinical studies, closely linked to our preclinical programs. These clinical studies deal with the development of molecular diagnostics, advancement of allogeneic stem cell transplantation, circumvention of drug-resistance to chemotherapy as well as a broad range of clinical phase I to phase III trials for a variety of hematological diseases.
For more information on clinical care for patients with hematological diseases please see our clinical homepage.
The Erasmus MC Hematology Department is excited to announce our new spring lecture series!Starting on January 27th, there will be webinars from excellent researchers covering a wide range of hematological (and related) topics.
On October 23rd 2024, Camille Kockerols successfully defended her thesis entitled ‘Prediction of treatment-free remission with BCR::ABL1 digital PCR and evolving treatment strategies in chronic myeloid leukemia’.
Dr Ningqing Liu has received a NWO grant for unraveling the role of the BAF-complex in gene regulation. NWO grants are intended for innovative, fundamental research of high quality and/or scientific urgency.
We are happy to announce the new Erasmus Hematology Lecture Series! Starting on September 2nd, there will be lectures from excellent researchers covering a wide range of hematological (and related) topics.
Prof Dr Ivo Touw from the Hematology department has received the David Grimwade Award. The European Hematology Association awards this prize annually to a leading researcher in hematology.
Prof Dr Marc Raaijmakers and co-authors have won a HemaSphere award for their article “Azacytidine Treatment for VEXAS Syndrome”, adding very important information to the understanding of the treatment for VEXAS syndrome. The award recognizes the importance of this study for the hematology field and for supporting HemaSphere, the open access journal of the European Hematology Association. Additionally, the publication is in the top 5 of HemaSphere’s highly cited papers from 2021.
The Spring digital lecture series starts on January 27th.
Everyone is invited to attend. Registration not necessary and attendance is free of charge.
If want to be updated on our lecture series and receive the links, subscribe to our newsletter here.
The 8th workshop on “Molecular aspects of hematological malignancies” will take place on 10 and 11 June in Rotterdam. This meeting is meant to give young investigators (PhD's or Postdocs) a platform to present their most recent work. It is a perfect moment for young investigators in our field to meet and create their own network.
You can find more information on the workshop website.
